A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body when given as Single and Multiple Doses

Trial Identifier:	D8170C00001
Sponsor:	MedImmune, LLC
NCTID::	NCT03362593
Start Date:	December 2017
Primary Completion Date:	May 2020
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version - Part A
	English version - Part B & C
	English version - Part D & F
	English version - Part E

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Ruddington, United Kingdom, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company